Filing Details
- Accession Number:
- 0001181431-12-039521
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-03 17:28:06
- Reporting Period:
- 2012-06-29
- Filing Date:
- 2012-07-03
- Accepted Time:
- 2012-07-03 17:28:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329505 | Gregory Bailey | C/O Medivation, Inc. 525 Market St., 36Th Floor San Francisco CA 94105 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-06-29 | 1,500 | $88.67 | 345,821 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-06-29 | 6,500 | $89.72 | 339,321 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-06-29 | 2,000 | $90.40 | 337,321 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-06-29 | 1,000 | $91.54 | 336,321 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-02 | 5,500 | $93.40 | 330,821 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-03 | 2,000 | $95.17 | 328,821 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The shares were sold at prices ranging from $88.64 to $88.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $89.20 to $90.15. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $93.05 to $93.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $95.05 to $95.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.